Data concordance between ESRD Medical Evidence Report and Medicare claims: is there any improvement?

被引:7
|
作者
Mu, Yi [1 ]
Chin, Andrew, I [2 ,3 ]
Kshirsagar, Abhijit, V [4 ,5 ]
Bang, Heejung [6 ,7 ]
机构
[1] Univ Calif San Francisco, UCSF Med Ctr, Off Populat Hlth & Accountable Care, San Francisco, CA 94143 USA
[2] Univ Calif Davis, Davis Sch Med, Div Nephrol, Sacramento, CA 95817 USA
[3] VA Northern Calif Hlth Care Syst, Sacramento VA Med Ctr, Div Nephrol, Mather Field, CA USA
[4] Univ North Carolina Chapel Hill, UNC Kidney Ctr, Chapel Hill, NC USA
[5] Univ North Carolina Chapel Hill, Div Nephrol & Hypertens, Chapel Hill, NC USA
[6] Univ Calif Davis, Div Biostat, Dept Publ Hlth Sci, Davis, CA 95616 USA
[7] Univ Calif Davis, Davis Sch Med, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA
来源
PEERJ | 2018年 / 6卷
基金
美国国家卫生研究院;
关键词
CMS-2728; ESRD; Claims; Comorbidity; USRDS; HOSPITAL READMISSION RATES; SOCIOECONOMIC-STATUS; DIALYSIS; VALIDATION; US;
D O I
10.7717/peerj.5284
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Medicare is one of the world's largest health insurance programs. It provides health insurance to nearly 44 million beneficiaries whose entitlements are based on age, disability, or end-stage renal disease (ESRD). Data of these ESRD beneficiaries are collected in the US Renal Data System (USRDS), which includes comorbidity information entered at the time of dialysis initiation (medical evidence data), and are used to shape health care policy. One limitation of USRDS data is the lack of validation of these medical evidence comorbidities against other comorbidity data sources, such as medical claims data. Methods. We examined the potential for discordance between USRDS Medical Evidence and medical claims data for 11 comorbid conditions amongst Medicare beneficiaries in 2011-2013 via sensitivity, specificity, kappa and hierarchical logistic regression. Results. Among 61,280 patients, most comorbid conditions recorded on the Medical Evidence forms showed high specificity (>0.9), compared to prior medical claims as reference standard. However, both sensitivity and kappa statistics varied greatly and tended to be low (most <0.5). Only diabetes appeared accurate, whereas tobacco use and drug dependence showed the poorest quality (sensitivity and kappa <0.1). Institutionalization and patient region of residency were associated with data discordance for six and five comorbidities out of 11, respectively, after conservative adjustment of multiple testing. Discordance appeared to be non-informative for congestive heart failure but was most varied for drug dependence. Conclusions. We conclude that there is no improvement in comorbidity data quality in incident ESRD patients over the last two decades. Since these data are used in case-mix adjustment for outcome and quality of care metrics, the findings in this study should press regulators to implement measures to improve the accuracy of comorbidity data collection.
引用
收藏
页数:16
相关论文
共 19 条
  • [1] Comorbidity Ascertainment From the ESRD Medical Evidence Report and Medicare Claims Around Dialysis Initiation: A Comparison Using US Renal Data System Data
    Krishnan, Mahesh
    Weinhandl, Eric D.
    Jackson, Scott
    Gilbertson, David T.
    Lacson, Eduardo, Jr.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (05) : 802 - 812
  • [2] Agreement of reported vascular access on the medical evidence report and on medicare claims at hemodialysis initiation
    Solid, Craig A.
    Collins, Allan J.
    Ebben, James P.
    Chen, Shu-Cheng
    Faravardeh, Arman
    Foley, Robert N.
    Ishani, Areef
    BMC NEPHROLOGY, 2014, 15
  • [3] Agreement of reported vascular access on the medical evidence report and on medicare claims at hemodialysis initiation
    Craig A Solid
    Allan J Collins
    James P Ebben
    Shu-Cheng Chen
    Arman Faravardeh
    Robert N Foley
    Areef Ishani
    BMC Nephrology, 15
  • [4] Concordance Between Electronic Health Record Data and Medicare Part D Claims Data for Oral Anticancer Drug Use
    Sharma, Manvi
    Johnson, Michael L.
    Zhao, Hui
    Giordano, Sharon H.
    Holmes, Holly M.
    JAMA NETWORK OPEN, 2020, 3 (04) : e203821
  • [5] Treatment Patterns for Prostate Cancer Comparison of Medicare Claims Data to Medical Record Review
    Fleming, Steven T.
    Hamilton, Ann S.
    Sabatino, Susan A.
    Kimmick, Gretchen G.
    Wu, Xiao-Cheng
    Owen, Jean B.
    Huang, Bin
    Hwang, Wenke
    MEDICAL CARE, 2014, 52 (09) : E58 - E64
  • [6] Validation of erythropoietin use data on Medicare's End-Stage Renal Disease Medical Evidence Report
    Fischer, Michael J.
    Stroupe, Kevin T.
    Hynes, Denise M.
    Blemur, Pierre
    Sohn, Min-Woong
    Browning, Margaret M.
    Huo, Zhiping
    O'Hare, Ann M.
    Kaufman, James S.
    JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT, 2010, 47 (08) : 751 - 762
  • [7] Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
    Onukwugha, Eberechukwu
    Yong, Candice
    Hussain, Arif
    Seal, Brian
    Mullins, C. Daniel
    BMC MEDICAL RESEARCH METHODOLOGY, 2014, 14
  • [8] Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
    Eberechukwu Onukwugha
    Candice Yong
    Arif Hussain
    Brian Seal
    C Daniel Mullins
    BMC Medical Research Methodology, 14
  • [9] Associations between environmental quality and adult asthma prevalence in medical claims data
    Gray, Christine L.
    Lobdell, Danelle T.
    Rappazzo, Kristen M.
    Jian, Yun
    Jagai, Jyotsna S.
    Messer, Lynne C.
    Patel, Achal P.
    DeFlorio-Barker, Stephanie A.
    Lyttle, Christopher
    Solway, Julian
    Rzhetsky, Andrey
    ENVIRONMENTAL RESEARCH, 2018, 166 : 529 - 536
  • [10] The ESRD Quality Incentive Program: The Current Limitations of Evidence and Data to Develop Measures, Drive Improvement, and Incentivize Outcomes
    Diamond, Louis H.
    Howard, Andrew D.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2016, 23 (06) : 377 - 384